✦ LIBER ✦

Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients

✍ Scribed by W.L Chak; K.S Choi; K.M Wong; Y.H Chan; K.F Chau; C.S Li

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preemptive Therapy in the Prevention of

✍ Casquero, S.; Rangel, D.; Lage, E.; Sobrino, M.; Cristobo, P.; Cordero, E.; Cisn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Preemptive Therapy for the Prevention of

✍ N. Paudice; A. Mehmetaj; M. Zanazzi; L. Moscarelli; R. Piperno; L. Di Maria; E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Prevention of cytomegalovirus infection

✍ Patricia L. Hibberd; Robert H. Rubin 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 820 KB

Prevention of cytomegalovirus infection

✍ A. Séchet; F. Bridoux; M. Bauwens; R.Abou Ayache; S. Belmouaz; G. Touchard 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Preemptive Therapy With Intravenous Ganc

✍ V. Monforte; A. Román; J. Gavaldà; C. Bravo; P. Gispert; A. Pahissa; F. Morell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Role of antiviral prophylaxis in renal t

✍ Cristina Costa; Massimiliano Bergallo; Rossana Cavallo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB